Skip to main content
. Author manuscript; available in PMC: 2009 Oct 11.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2009 Apr 17;2(4):362–369. doi: 10.1161/CIRCEP.108.837294

Figure 3.

Figure 3

AAD Markov process. The three main treatment options in the AAD group are shown from top to bottom on the left. Within each well state, patients may experience recurrent symptomatic AF or drug toxicity, in which case they would progress to the next treatment (“next Rx”), or they could remain well. All failures of first line drug treatment would next try amiodarone, and all amiodarone failures would move on to rate control and anticoagulation (“RC/AC”).